CL
ALNY icon

Choreo LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Choreo LLC’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$834K Buy
2,770
+59
+2% +$17.8K 0.01% 733
2026
Q1 		$897K Buy
2,711
+136
+5% +$46.3K 0.01% 661
2025
Q4 		$1.02M Sell
2,575
-189
-7% -$83.6K 0.01% 588
2025
Q3 		$1.26M Sell
2,764
-1,639
-37% -$667K 0.02% 514
2025
Q2 		$1.44M Buy
4,403
+221
+5% +$61.2K 0.02% 457
2025
Q1 		$1.13M Sell
4,182
-566
-12% -$145K 0.02% 514
2024
Q4 		$1.12M Buy
4,748
+378
+9% +$99.4K 0.02% 535
2024
Q3 		$1.21M Buy
4,370
+1,261
+41% +$328K 0.02% 508
2024
Q2 		$756K Buy
+3,109
New +$491K 0.01% 629

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Choreo LLC's ALNY Position: Q2 2026 in Review

Choreo LLC increased its Alnylam Pharmaceuticals (ALNY) stake by 2.2% in Q2 2026, buying an estimated $17.8K and bringing the position to 2,770 shares worth $834K. The position accounts for 0.01% of the portfolio, ranked #733.

Choreo LLC first reported a position in ALNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.44M in Q2 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Choreo LLC held 2,770 shares of Alnylam Pharmaceuticals worth $834K as of Q2 2026.
  • Choreo LLC bought 59 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $17.8K.
  • Alnylam Pharmaceuticals made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #733 holding.
  • Choreo LLC first reported a position in Alnylam Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Alnylam Pharmaceuticals position peaked at $1.44M in Q2 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.